Quest for the right Drug
ארטיקאין 4% ואפינפרין 1:200,000 ARTICAINE HCL 4 % AND EPINEPHRINE 1 : 200,000 (ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
חסם עצב דנטלי, הזרקה שינית מוחדרת : DENTAL NERVE BLOCK, DENTAL INFILTRATION INJ.
צורת מינון:
תמיסה להזרקה : SOLUTION FOR INJECTION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Posology : מינונים
4.2 Posology and method of administration The following dosage instructions apply: The smallest possible volume of solution which will lead to an effective anaesthesia should be used. For extraction of maxillary teeth, 1.7 ml Articaine HCl 4% and Epinephrine 1:200,000 per tooth suffices in most cases; painful palatal injections can thus be avoided. In the case of serial extractions of neighbouring teeth, a reduction of the injection volume is often possible. If a cut or suture is required in the palate, a palatal injection of approx 0.1 ml per puncture is indicated. For smooth extractions of mandibular premolar teeth, infiltration anaesthesia of 1.7 ml Articaine HCl 4% and Epinephrine 1:200,000 per tooth is mostly sufficient; in single cases a buccal re-injection of 1 to 1.7 ml is required. An injection into the mandibular foramen can be indicated in rare cases. Vestibular injections of 0.5 - 1.7 ml Articaine HCl 4% and Epinephrine 1:200,000 per tooth enable cavity and crown-stump preparations. Nerve-block anaesthesia should be used in the treatment of mandibular molar teeth. Generally, in children weighing about 20 - 30 kg, doses of 0.25 - 1 ml are sufficient; in children weighing 30 - 45 kg, 0.5 - 2 ml. Articaine HCl 4% and Epinephrine 1:200,000 must not be used with children aged under 4 years (see section 4.3). Increased plasma levels of Articaine HCl 4% and Epinephrine 1:200,000 can occur in older patients due to diminished metabolic processes and lower distribution volume. The risk of accumulation of Articaine HCl 4% and Epinephrine 1:200,000 is increased in particular after repeated application (e.g. re-injection). A similar effect can ensue from the reduced general condition of the patient, as well as severely impaired hepatic and renal function (see also section 4.4). A lower dosage range is thus recommended in all such cases (minimum quantity for sufficient anaesthetic depth). The dose has to be likewise reduced in patients with certain pre-existing diseases (angina pectoris, arteriosclerosis) (see also section 4.4). Maximum Recommended Dosage: Adults: For healthy adults, the maximum dose is 7 mg/kg body weight articaine (500 mg for a 70 kg patient), equivalent to 12.5 ml Articaine HCl 4% and Epinephrine 1:200,000. The maximum dose represents 0.175 ml of solution per kg. Children: The quantity to be injected should be determined by the age and weight of the child and the magnitude of the operation. Do not exceed the equivalent of 7 mg articaine/kg (0.175 ml Articaine HCl 4% and Epinephrine 1:200,000 /kg) of body weight. Espestesin 4 % articaine with 1/100:000 adrenaline (epinephrine) is also available and may be more appropriate for procedures of longer duration and when there is a risk of significant bleeding into operative field (see section 5.1 for more information on duration of analgesia). Method of administration For injection/oromucosal use FOR USE IN DENTAL ANAESTHESIA ONLY To avoid intravascular injection, aspiration control at least in two planes (rotation of the needle by 180°) must always be carefully undertaken, although a negative aspiration result does not safely rule out an unintentional and unnoticed intravascular injection. The injection rate should not exceed 0.5 ml in 15 seconds, i.e. 1 cartridge per minute. Major systemic reactions as a result of accidental intravascular injection can be avoided in most cases by an injection technique – after aspiration slow injection of 0.1 – 0.2 ml and slow application of the rest – not earlier than 20 – 30 seconds later. Opened cartridges must not be used in other patients. Residues must be discarded.
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף